|
Viveon Health Acquisition Corp (VHAQ) |
|
Viveon Health Acquisition Corp
VHAQ's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Viveon Health Acquisition growth rates, revenue grew
in I. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -8.34 %
Viveon Health Acquisition realized net income compared to net loss a year ago in I. Quarter 2023
• More on VHAQ's Growth
|
|
Viveon Health Acquisition current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Viveon Health Acquisition PEG ratio is at -0.17
Viveon Health Acquisition realized cash reduction of $ -0.34 per share in trailing twelve-month period. |
Company |
75.94 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.33.
• More on VHAQ's Valuation
|
|
|
|
|
Viveon Health Acquisition current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Viveon Health Acquisition PEG ratio is at -0.17
Viveon Health Acquisition realized cash outflow of $ -0.34per share in trailing twelve-month period. |
Company |
75.94 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.33.
• More on VHAQ's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com